Combination drug

Results: 675



#Item
661Peri- and Postanalgesic Properties of Lidokain, Lornoxicam, and Nitroglycerine Combination at Intravenous Regional Anesthesia

Peri- and Postanalgesic Properties of Lidokain, Lornoxicam, and Nitroglycerine Combination at Intravenous Regional Anesthesia

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Language: English
662TIVICAY(dolutegravir) Tablets for Oral Use

TIVICAY(dolutegravir) Tablets for Oral Use

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2013-08-19 16:16:52
663GILEAD SCIENCES ANNUAL REPORT 2012  WELCOME TO

GILEAD SCIENCES ANNUAL REPORT 2012 WELCOME TO

Add to Reading List

Source URL: us.gilead.com

Language: English - Date: 2013-04-17 22:09:31
664----------------------- WARNINGS AND PRECAUTIONS ----------------------• Hypersensitivity reactions characterized by rash, constitutional findings, and sometimes organ dysfunction, including liver injury, have been reported. Discontinue TIVICAY and other suspect agents immediately if

----------------------- WARNINGS AND PRECAUTIONS ----------------------• Hypersensitivity reactions characterized by rash, constitutional findings, and sometimes organ dysfunction, including liver injury, have been reported. Discontinue TIVICAY and other suspect agents immediately if

Add to Reading List

Source URL: www.viivhealthcare.com

Language: English
665OTC DRUG LIST E ffective M ay[removed]

OTC DRUG LIST E ffective M ay[removed]

Add to Reading List

Source URL: www.passporthealthplan.com

Language: English - Date: 2012-06-04 12:00:48
666Acetaminophen: Background and Overview Gerald J. Dal Pan, MD, MHS

Acetaminophen: Background and Overview Gerald J. Dal Pan, MD, MHS

Add to Reading List

Source URL: www.fda.gov

Language: English
667CE CREDIT  Combination Drugs:

CE CREDIT Combination Drugs:

Add to Reading List

Source URL: www.pharmscope.com

Language: English - Date: 2006-10-25 15:39:06
668AAPHP E-cigarette Petitions to FDA – Actions Requested and Justification Action Requested – Petition to Reclassify E-cigarettes from “Drug Device Combination” to “Tobacco Product” AAPHP urges the Food and Drug Administration (FDA) to reclassify nicotine vaporizers (E-cigarettes) from “drugdevice combination” to “tobacco product.” This reclassification would be limited to E-cigarettes marketed as an

AAPHP E-cigarette Petitions to FDA – Actions Requested and Justification Action Requested – Petition to Reclassify E-cigarettes from “Drug Device Combination” to “Tobacco Product” AAPHP urges the Food and Drug Administration (FDA) to reclassify nicotine vaporizers (E-cigarettes) from “drugdevice combination” to “tobacco product.” This reclassification would be limited to E-cigarettes marketed as an

Add to Reading List

Source URL: www.aaphp.org

Language: English - Date: 2011-07-23 03:54:04
669

PDF Document

Add to Reading List

Source URL: www.merck.com

Language: English - Date: 2015-03-26 19:23:33
670

PDF Document

Add to Reading List

Source URL: www.pharma.us.novartis.com

Language: English - Date: 2012-11-23 13:22:58